US Patent Issued to IGI THERAPEUTICS on July 28 for "CD3/BCMA/CD38 trispecific antibodies" (Swiss Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,314, issued on July 28, was assigned to IGI THERAPEUTICS SA (Neuchatel, Switzerland).

"CD3/BCMA/CD38 trispecific antibodies" was invented by Maria Pihlgren Bosch (La Chaux-de-Fonds, Switzerland), Mario Perro (La Chaux-de-Fonds, Switzerland), Olivia Hall (La Chaux-de-Fonds, Switzerland), Laura Carretero Iglesia (La Chaux-de-Fonds, Switzerland), Adam Drake (La Chaux-de-Fonds, Switzerland), Daniela Pais (La Chaux-de-Fonds, Switzerland), Rebecca Croasdale-Wood (La Chaux-de-Fonds, Switzerland), Carole Estoppey (La Chaux-de-Fonds, Switzerland), Michael Dyson (La Chaux-de-Fonds, Switzerland) and Thierry Monney (La Chaux-de-Fonds, Switzerland).

According to the abstract* released by the ...